The partnership aims to bridge the gap between academia and industry by developing science-based nutritional innovations for improved metabolic health
Some emerging technologies, like microneedle-style patches, might eventually offer a more direct way to deliver medication
Research published in Cell Metabolism identified P9 as an 84 kilodalton protein that directly binds to intercellular adhesion molecule 2 (ICAM-2) on the surface of intestinal L cells
Consequently, this results in a reduction of blood glucose levels and a decrease in body weight
The Medicare GLP-1 Bridge is a nationwide demonstration program that will be separate from Part D coverage, meaning Part D sponsors will not have to opt into the demonstration for eligible beneficiaries to gain access, nor will Part D sponsors bear any financial risk for costs incurred by their enrollees associated with the demonstration
If your BMI is below 27, current medical guidelines do not recommend tirzepatide for weight loss
